paxilline has been researched along with uridine triphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christophersen, P; Dissing, S; Olesen, SP; Strøbaek, D | 1 |
| O'Grady, SM; Panoskaltsis-Mortari, A; Zaidman, NA | 1 |
2 other study(ies) available for paxilline and uridine triphosphate
| Article | Year |
|---|---|
ATP activates K and Cl channels via purinoceptor-mediated release of Ca2+ in human coronary artery smooth muscle.
Topics: Adenosine Triphosphate; Calcium; Cells, Cultured; Chloride Channels; Coronary Vessels; Egtazic Acid; Humans; Indoles; Kinetics; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium Channels; Receptors, Purinergic P2; Tetraethylammonium; Tetraethylammonium Compounds; Thionucleotides; Time Factors; Uridine Triphosphate | 1996 |
Large-conductance Ca
Topics: Adenosine Triphosphate; Bronchi; Cell Differentiation; Cell Line; Epithelial Cells; Humans; Hydrocortisone; Indoles; Large-Conductance Calcium-Activated Potassium Channels; Maleimides; Potassium Channel Blockers; Protein Kinase C; Protein Kinase Inhibitors; Purinergic P2Y Receptor Agonists; Receptors, Purinergic P2Y; Respiratory Mucosa; Uridine Triphosphate | 2017 |